SYGNIS announces Genetrix S.L. has taken over all shares from Genetrix Life Sciences AB to become new majority shareholder
- Genetrix S.L., as the parent company, now acts as a direct shareholder
- No substantial change in SYGNIS shareholder structure
Madrid, Spain and Heidelberg, Germany, June 3rd, 2015 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Genetrix S.L. has informed the Company that it has transferred all common shares currently held by Genetrix Life Sciences AB to Genetrix S.L.
Due to internal corporate changes, Genetrix S.L. will assume the shareholding in SYGNIS AG from its fully owned subsidiary Genetrix Life Sciences AB. In light of the holding transfer, Genetrix S.L. will become the majority shareholder in SYGNIS. Genetrix S.L. has informed the Company that it has filed the transfer of all common shares currently held by Genetrix Life Sciences AB to Genetrix S.L. with the BaFin. This transfer does not represent any change to SYGNIS’ ownership structure.
For further information please contact:
Pilar de la Huerta
Phone: +34 91 192 36 50
MC Services AG
Phone: +49 89 210228 30